Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (11): 1194-1200.doi: 10.3969/j.issn.1000-6621.2018.11.010
• Original Articles • Previous Articles Next Articles
Received:
2018-06-19
Online:
2018-11-10
Published:
2018-12-04
Contact:
Hong DING
E-mail:13911883299@163.com
WANG Zhi-gang,DING Hong. Analysis of reasons on misdiagnosing as tuberculous pleurisy in 17 cases with malignant pleural mesothelioma[J]. Chinese Journal of Antituberculosis, 2018, 40(11): 1194-1200. doi: 10.3969/j.issn.1000-6621.2018.11.010
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.11.010
患者 编号 | 性 别 | 年龄 (岁) | 部 位 | 临床表现 | 病程 (d) | 误诊 时间 (d) | 实验室检查 | 既往史 | 胸腔穿刺液 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
胸 痛 | 胸 闷 | 咳 嗽 | 消瘦 乏力 | 发 热 | PPD 试验 | T-SPOT. TB | 吸 烟 | 肺结核 | 石 棉 | 颜色 | 性质 | WBC (×106/L) | LDH (U/L) | ADA (U/L) | CEA (μg/L) | 脱落 细胞 | |||||||
1 | 男 | 31 | 右 | 有 | 无 | 有 | 无 | 有 | 30 | 32 | + | - | 无 | 无 | 无 | 黄 | 渗出 | 2400 | 314 | 16 | 4.3 | 无 | |
2 | 男 | 32 | 右 | 有 | 有 | 无 | 有 | 无 | 10 | 90 | +++ | - | 有 | 无 | 无 | 黄 | 渗出 | 4600 | 285 | 18 | 3.5 | 无 | |
3 | 男 | 34 | 左 | 有 | 无 | 有 | 无 | 无 | 15 | 12 | - | - | 无 | 无 | 无 | 黄 | 渗出 | 2600 | 298 | 20 | 3.9 | 有 | |
4 | 女 | 37 | 右 | 有 | 有 | 有 | 无 | 有 | 10 | 48 | + | + | 无 | 无 | 无 | 黄-血 | 渗出 | 1300 | 554 | 32 | 4.3 | 无 | |
5 | 男 | 39 | 双 | 无 | 有 | 无 | 无 | 无 | 5 | 6 | - | - | 无 | 无 | 无 | 橘红 | 渗出 | 5800 | 278 | 19 | 4.1 | 有 | |
6 | 男 | 40 | 右 | 有 | 无 | 有 | 无 | 无 | 7 | 58 | - | + | 有 | 无 | 无 | 黄 | 渗出 | 6400 | 306 | 36 | 3.8 | 无 | |
7 | 女 | 41 | 左 | 有 | 有 | 无 | 有 | 无 | 90 | 42 | + | - | 无 | 无 | 无 | 橘红 | 渗出 | 3600 | 312 | 17 | 4.6 | 无 | |
8 | 男 | 41 | 右 | 有 | 有 | 有 | 无 | 无 | 10 | 55 | - | - | 无 | 无 | 无 | 黄 | 渗出 | 3500 | 412 | 18 | 4.5 | 无 | |
9 | 男 | 43 | 右 | 有 | 无 | 无 | 有 | 无 | 7 | 37 | - | - | 有 | 无 | 无 | 黄 | 渗出 | 4200 | 494 | 21 | 8.6 | 无 | |
10 | 男 | 44 | 左 | 有 | 有 | 无 | 无 | 有 | 60 | 18 | ++ | - | 无 | 无 | 无 | 橘红 | 渗出 | 1800 | 354 | 22 | 3.8 | 有 | |
11 | 女 | 46 | 右 | 有 | 有 | 有 | 有 | 无 | 14 | 270 | - | + | 无 | 有 | 无 | 橘红 | 渗出 | 2700 | 323 | 20 | 2.9 | 有 | |
12 | 男 | 46 | 左 | 有 | 有 | 无 | 无 | 无 | 7 | 23 | ++ | + | 有 | 无 | 无 | 黄 | 渗出 | 7500 | 724 | 38 | 5.0 | 有 | |
13 | 女 | 48 | 双 | 有 | 无 | 有 | 无 | 无 | 10 | 15 | - | + | 无 | 有 | 无 | 橘红 | 渗出 | 4500 | 1518 | 45 | 4.8 | 有 | |
14 | 女 | 51 | 右 | 无 | 有 | 有 | 有 | 无 | 21 | 540 | + | - | 有 | 无 | 无 | 黄 | 渗出 | 3800 | 271 | 22 | 4.9 | 有 | |
15 | 男 | 63 | 左 | 有 | 有 | 无 | 无 | 无 | 30 | 43 | +++ | + | 有 | 无 | 无 | 黄 | 渗出 | 2900 | 353 | 16 | 4.5 | 有 | |
16 | 男 | 67 | 右 | 有 | 无 | 有 | 无 | 无 | 21 | 36 | - | - | 无 | 无 | 有 | 黄-血 | 渗出 | 2100 | 329 | 56 | 9.2 | 有 | |
17 | 男 | 72 | 左 | 无 | 有 | 无 | 无 | 无 | 30 | 45 | - | - | 无 | 无 | 无 | 橘红 | 渗出 | 1600 | 351 | 39 | 4.2 | 有 |
[1] | 梅周芳, 钱凌, 都勇 , 等. 恶性胸膜间皮瘤误诊为结核性胸膜炎原因分析. 临床误诊误治, 2015,28(1):45-48. |
[2] |
吴小燕, 于学燕 . 恶性胸膜间皮瘤的临床特点及鉴别诊断. 中国老年学杂志, 2016,36(15):3747-3748.
doi: 10.3969/j.issn.1005-9202.2016.15.063 URL |
[3] |
张建国, 张惠珍 . 恶性胸膜间皮瘤诊断方法探讨. 内蒙古医学院学报, 2002,24(1):48-49.
doi: 10.3969/j.issn.1004-2113.2002.01.019 URL |
[4] | 吴树才, 张玲, 张新 , 等. 结核性胸膜炎研究进展. 临床荟萃, 2016,31(10):1048-1054. |
[5] | 张幸, 楼建林, 郑建军 , 等. 恶性胸膜间皮瘤诊疗共识(试行). 肿瘤学杂志, 2017,23(11):1047-1050. |
[6] |
Davidson B . Prognostic factors in malignant pleural mesothelioma. Hum Pathol, 2015,46(6):789-804.
doi: 10.1016/j.humpath.2015.02.006 URL pmid: 25824607 |
[7] |
Sekido Y . Molecular pathogenesis of malignant mesothelioma. Carcinogenesis, 2013,34(7):1413-1419.
doi: 10.1093/carcin/bgt166 URL pmid: 23677068 |
[8] |
Robinson BW, Lake RA . Advances in malignant mesothelioma. N Engl J Med, 2005,353(15):1591-1603.
doi: 10.1056/NEJMra050152 URL |
[9] |
Scherpereel A, Astoul P, Baas P , et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J, 2010,35(3):479-495.
doi: 10.3779/j.issn.1009-3419.2010.10.14 URL pmid: 20976998 |
[10] |
李娜, 轩菡, 陈婷婷 , 等. 恶性胸膜间皮瘤伴腹膜广泛病变1 例报告. 安徽医学, 2014,35(5):707-708.
doi: 10.3969/j.issn.1000-0399.2014.05.052 URL |
[11] |
de Lima VA, Sørensen JB . Third-line chemotherapy with carboplatin, gemcitabine and liposomised doxorubicin for malignant pleural mesothelioma. Med Oncol, 2015,32(2):458.
doi: 10.1007/s12032-014-0458-x URL pmid: 25572813 |
[12] |
于静 .恶性胸膜间皮瘤误诊为结核性胸膜炎临床分析 .中国社区医师, 2016, 32(15): 181, 183.
doi: 10.3969/j.issn.1007-614x.2016.15.111 URL |
[13] |
魏星, 杨淑苓 . 22例恶性胸膜间皮瘤的诊断与分析. 中国防痨杂志, 2006,28(1):40-41.
doi: 10.3969/j.issn.1000-6621.2006.01.012 URL |
[14] |
肖奎, 夏莹, 胡成平 , 等. 胸膜间皮瘤39例临床分析. 中华结核和呼吸杂志, 2007,30(6):472.
doi: 10.3760/j.issn:1001-0939.2007.06.016 URL |
[15] |
黄毅华, 罗萍, 李应平 , 等. CT 鉴别恶性胸膜间皮瘤与结核性脓胸的应用价值分析. 中国CT和MRI杂志, 2014,12(9):78-80,88.
doi: 10.3969/j.issn.1672-5131.2014.09.26 URL |
[16] |
丁春晓, 张洋, 张恒 , 等. 联合抗体免疫组织化学检测胸水细胞对恶性间皮瘤诊断的应用价值分析. 中国组织化学与细胞化学杂志, 2016,25(2):163-168.
doi: 10.16705/j.cnki.1004-1850.2016.02.012 URL |
[17] |
WHO Guidelines Approved by the Guidelines Review Committee. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update. Geneva:World Health Organization, 2013.
doi: 10.1111/j.1468-0289.2005.00321.x URL pmid: 26158191 |
[18] | 任文浩, 曹箭 . 浆膜腔积液细胞学诊断在恶性间皮瘤中的应用研究进展. 癌症进展, 2017,15(2):119-122. |
[19] |
Hjerpe A, Ascoli V, Bedrossian C , et al. Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology. Cytojournal, 2015,12:26.
doi: 10.4103/1742-6413.170726 URL |
[20] | 李青 . 胸膜间皮瘤误诊为结核性胸膜炎2例分析. 中国误诊学杂志, 2011,11(19):4674. |
[21] |
刘标, 周晓军 . 恶性间皮瘤的病理诊断. 诊断病理学杂志, 2014,21(1):1-3.
doi: 10.13315/j.cnki.cjcep.2014.10.019 URL |
[22] | 余英豪, 刘伟 . 恶性间皮瘤的免疫组化诊断. 诊断病理学杂志, 2014,21(5):257-259. |
[23] |
Husain AN, Colby T, Ordonez N , et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med, 2013,137(5):647-667.
doi: 10.5858/arpa.2012-0214-OA URL pmid: 22929121 |
[24] |
龙四军, 周向东 . 骨桥蛋白对恶性胸膜间皮瘤诊断价值的 Meta分析. 医学研究杂志, 2016,45(5):155-159.
doi: 10.11969/j.issn.1673-548X.2016.05.039 URL |
[25] |
Cristaudo A, Bonotti A, Simonini S , et al. Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. J Thorac Oncol, 2011,6(9):1587-1593.
doi: 10.1097/JTO.0b013e31821e1c08 URL pmid: 21642872 |
[26] | 李康 . 胸膜间皮瘤的CT诊断与鉴别诊断. 中国肿瘤外科杂志, 2016,8(6):405-406. |
[27] | 杨汉卿, 姚伟根, 黄国来 , 等. 多层螺旋CT在恶性胸膜间皮瘤诊断中的价值. 肿瘤学杂志, 2014,20(10):859-862. |
[28] |
吴万鹏, 宁晖 . 恶性胸膜间皮瘤及其诊断进展. 临床肺科杂志, 2007,12(4):364-365.
doi: 10.3969/j.issn.1009-6663.2007.04.022 URL |
[29] |
王晓虹, 张群, 刘永 . 23例恶性胸膜间皮瘤误诊分析. 中国临床实用医学, 2009,3(5):121.
doi: 10.3760/cma.j.issn.1673-8799.2009.05.79 URL |
[30] | 王文军 . 多层螺旋CT在恶性胸膜间皮瘤诊断中的应用. 医疗装备, 2017,30(20):21-22. |
[31] |
肖晓辉, 刘华, 蔡曦光 , 等. 青年恶性胸膜间皮瘤1 例临床分析. 国际呼吸杂志, 2014,34(6):405-407.
doi: 10.3760/cma.j.issn.1673-436X.2014.06.002 URL |
[32] | 牟向东, 章巍, 柳萍 , 等. 内科胸腔镜结合免疫组织化学及电镜技术诊断恶性胸膜间皮瘤一例. 中国呼吸与危重监护杂志, 2015,14(3):298-300. |
[33] | 罗慰慈 . 现代呼吸病学.北京: 人民军医出版社, 1997: 967-968. |
[34] |
Robinson BW, Musk AW, Lake RA . Malignant mesothelioma. Lancet, 2005,366(9483):397-408.
doi: 10.1016/S0140-6736(05)67025-0 URL |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||